Impact of operative and peri-operative factors on the long-term prognosis of primary liver cancer patients undergoing hepatectomy

Abstract

This study examined the impact of the operative and peri-operative factors on the long-term prognosis of patients with primary liver cancer undergoing hepatectomy. A total of 222 patients with primary liver cancer who underwent hepatectomy were followed up from January 1986 to December 2010 at Chinese PLA General Hospital. The post-operative complication rate was 14.0% for all cases, 13.7% for hepatocellular carcinoma (HCC), 10.0% for cholangiocarcinoma. The 1-, 3-, 5- and 10-year overall survival rates in patients with primary liver cancer after resection were 76.6%, 57.6%, 41.4%, and 21.0%. The survival rates were significantly higher in the HCC group than in the cholangiocarcinoma group (P=0.000), in the non-anatomical resection group than in the anatomical resection group (P=0.005), in the female group than in the male group (P=0.002), in patients receiving no blood transfusion than in those who were given intra-operative blood transfusion (P=0.000), in patients whose intra-operative blood loss was less than 400 mL than in those who intra-operatively lost more than 400 mL (P=0.000). No significant difference was found in the survival rate between the HBsAg-positive group and the HBsAg-negative group (P=0.532). Our study showed that anatomical resection, blood loss and blood transfusion were predictors of poor survival after hepatectomy for primary liver cancer patients, and concomitant hepatitis B virus infection bore no relation with the post-resection survival.

Keywords

primary liver cancer / prognosis / hepatectomy / perioperative time / influencing factors

References

[1] KudoM. Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan. Liver Cancer, 2015, 4(1): 39-50 PMID: 26020028 PMCID: 4439792

[2] ZhangY, RenJS, ShiJF, et al. . International trends in primary liver cancer incidence from 1973 to 2007. BMC Cancer, 2015, 15: 94 PMID: 25879744 PMCID: 4359785

[3] SrivatanakulP, SriplungH, DeerasameeS. Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev, 2004, 5(2): 118-125 PMID: 15244512

[4] IkaiI, AriiS, OkazakiM, et al. . Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res, 2007, 37(9): 676-691 PMID: 17617112

[5] YanoY, YamamotoJ, KosugeT, et al. . Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol, 2003, 33(6): 283-287 PMID: 12913082

[6] LeeWS, LeeKW, HeoJS, et al. . Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today, 2006, 36(10): 892-897 PMID: 16998683

[7] YinX, ZhangBH, QiuSJ, et al. . Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol, 2012, 19(9): 2869-2876 PMID: 22451237

[8] JinS, FuQ, WuyunG, et al. . Management of post-hepatectomy complications. World J Gastroenterol, 2013, 19(44): 7983-7991 PMID: 24307791 PMCID: 3848145

[9] WuMC, ChenH, ShenF. Surgical treatment of primary liver cancer: report of 5,524 patients. Zhonghua Waike Zazhi (Chinese), 2001, 39(6): 417-421

[10] HanazakiK, KajikawaS, ShimozawaN, et al. . Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg, 2000, 191(4): 381-388 PMID: 11030243

[11] HanSL, ZhuGB, YaoJG, et al. . Diagnosis and surgical treatment of primary hepatic cholangiocarcinoma. Hepatogastroenterology, 2005, 52(62): 348-351 PMID: 15816432

[12] GiulianteF, GauzolinoR, VelloneM, et al. . Liver resection for intrahepatic cholangiocarcinoma. Tumori, 2005, 91(6): 487-492 PMID: 16457147

[13] CucchettiA, CesconM, ErcolaniG, et al. . A comprehensive meta-regression analysis on outcome of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Ann Surg Oncol, 2012, 19(12): 3697-3705 PMID: 22722807

[14] ChenJ, HuangK, WuJ, et al. . Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci, 2011, 56(6): 1626-1633 PMID: 21082347

[15] ZhouY, XuD, WuL, et al. . Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Langenbecks Arch Surg, 2011, 396(7): 1109-1117 PMID: 21476060

[16] ManK, LoCM, XiaoJW, et al. . The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg, 2008, 247(6): 1049-1057 PMID: 18520234

[17] HarunN, NikfarjamM, MuralidharanV, et al. . Liver regeneration stimulates tumor metastases. J Surg Res, 2007, 138: 284 PMID: 17254608

[18] ShiJH, LinePD. Effect of liver regeneration on malignant hepatic tumors. World J Gastroenterol, 2014, 20(43): 16167-16177 PMID: 25473170 PMCID: 4239504

[19] YokoiY, SuzukiS, BabaS, et al. . Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection. J Gastroenterol, 2005, 40(3): 274-282 PMID: 15830287

[20] TechathuvananK, SrisajjakulS, PongpaibulA, et al. . Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis. J Med Assoc Thai, 2015, 98(4): 334-342 PMID: 25958707

[21] ChenPH, LinYC, TuHP, et al. . Important prognostic factors for the long-term survival of subjects with primary liver cancer in Taiwan: a hyperendemic area. Eur J Cancer, 2007, 43(6): 1076-1084 PMID: 17329095

[22] ShibaH, IshidaY, FujiwaraY, et al. . Practice to minimize the use of blood products improve outcome after hepatic resection for hepatocellular carcinoma. Hepatogastroenterology, 2013, 60(127): 1681-1683 PMID: 24634937

[23] KatzSC, ShiaJ, LiauKH, et al. . Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg, 2009, 249(4): 617-6239 PMID: 19300227